# Breast Cancer - [Breast Cancers Overview](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/breast-cancers-overview.md): Overview of the breast-cancer space, including subtype hubs and shared cross-subtype topics - [HER2-Positive](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/her2-positive.md) - [HER2CLIMB](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/her2-positive/her2climb.md) - [HER2CLIMB Guide](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/her2-positive/her2climb/her2climb-guide.md): Central guide to HER2CLIMB resistance, testing, tucatinib clearance, and supplement-interaction pages across the site - [HER2CLIMB Resistance Mechanisms](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/her2-positive/her2climb/her2climb-resistance-mechanisms.md): Possible molecular and clinical mechanisms that may drive progression on the tucatinib, trastuzumab, and capecitabine regimen - [Liquid Biopsy for HER2-Positive Resistance](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/her2-positive/her2climb/liquid-biopsy-for-her2-positive-resistance.md): How ctDNA testing may help identify resistance mechanisms in HER2-positive breast cancer, including after tucatinib-based therapy - [Tucatinib Clearance, Genetics, and Enzyme Inducers](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/her2-positive/her2climb/tucatinib-clearance-genetics-and-enzyme-inducers.md): How CYP3A4, CYP2C8, genetic variation, and enzyme inducers may affect tucatinib exposure in the HER2CLIMB setting - [Natural Compounds and CYP3A4 — HER2CLIMB Considerations](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/her2-positive/her2climb/natural-compounds-and-cyp3a4-her2climb-considerations.md): Practical overview of how commonly used supplements may affect CYP3A4 in the tucatinib-based HER2CLIMB regimen - [Enhertu, Senescence, and the Senolytic Second Strike](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/her2-positive/enhertu-senescence-and-the-senolytic-second-strike.md): How trastuzumab deruxtecan interacts with cellular senescence and dormancy — and why a timed senolytic strategy may matter after each cycle. - [Should HER2+/ERα+ Patients Avoid Resveratrol or Polydatin?](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/her2-positive/should-her2+-era+-patients-avoid-resveratrol-or-polydatin.md): Research note on the caution around resveratrol or polydatin in Luminal B HER2-positive, ERα-positive breast cancer - [HER2+ Breast Cancer – Integrative Protocols](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/her2-positive/her2+-breast-cancer-integrative-protocols.md): Group and support resource notes for HER2-positive breast-cancer patients exploring integrative protocols - [Support Threads & Docs](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/her2-positive/support-threads-and-docs.md): Facebook study-support threads and Google Doc links relevant to HER2-positive breast cancer - [ER-Positive / HER2-Negative](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative.md): Estrogen-receptor-positive/HER2-negative breast cancer research summaries that need their own treatment and resistance contexts. - [New BCL‑2 Inhibitor Trial in HR+ MBC – and Why Whack-a-Mole Still Matters](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/new-bcl-2-inhibitor-trial-in-hr+-mbc-and-why-whack-a-mole-still-matters.md): This trial is exciting because it is a much more direct attempt to force cancer cells into apoptosis than any standard of care ER+ therapy has attempted. - [Endocrine therapy, resistance, and dormancy](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/endocrine-therapy-resistance-and-dormancy.md) - [CDK4/6 Options and Supplement Considerations](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/endocrine-therapy-resistance-and-dormancy/cdk4-6-options-and-supplement-considerations.md): Balanced look at palbociclib, ribociclib, and abemaciclib in HR-positive disease, including supplement considerations and monitoring questions - [SONIA Trial and CDK4/6 Timing](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/endocrine-therapy-resistance-and-dormancy/cdk4-6-options-and-supplement-considerations/sonia-trial-and-cdk4-6-timing.md): What the SONIA phase 3 trial suggests about first-line versus second-line CDK4/6 inhibitor sequencing in HR-positive, HER2-negative advanced breast cancer - [Galectin‑3, Cyclin D1, Modified Citrus Pectin(MCP) and CDK4/6: A Patient Guide](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/endocrine-therapy-resistance-and-dormancy/cdk4-6-options-and-supplement-considerations/galectin-3-cyclin-d1-modified-citrus-pectin-mcp-and-cdk4-6-a-patient-guide.md): This page explains how galectin‑3 (Gal‑3) connects to the same cell‑cycle pathway targeted by CDK4/6 inhibitors, and why people are talking about MCP and diet. - [Autophagy Escape in ER-Positive Breast Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/endocrine-therapy-resistance-and-dormancy/autophagy-escape-in-er-positive-breast-cancer.md): Why mTOR pressure, glycolysis, PI3K inhibition, dormancy, and hydroxychloroquine come up in ER-positive/HER2-negative disease, with or without known TP53 status - [Autophagy and Senescence in Antiestrogen Resistance](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/endocrine-therapy-resistance-and-dormancy/autophagy-and-senescence-in-antiestrogen-resistance.md): Plain-language guide to the 2024 review on how autophagy and reversible senescence may help ER-positive breast cancer survive endocrine therapy and CDK4/6 pressure - [Overview and key takeaways](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/endocrine-therapy-resistance-and-dormancy/autophagy-and-senescence-in-antiestrogen-resistance/overview-and-key-takeaways.md): Plain-language overview of why autophagy and reversible senescence matter in ER-positive antiestrogen resistance - [Endocrine therapy, CDK4/6, and why resistance still happens](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/endocrine-therapy-resistance-and-dormancy/autophagy-and-senescence-in-antiestrogen-resistance/endocrine-therapy-cdk4-6-and-why-resistance-still-happens.md): How ER-positive treatments work, where they help most, and why many cancers still find a way to survive - [Autophagy — the first escape route](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/endocrine-therapy-resistance-and-dormancy/autophagy-and-senescence-in-antiestrogen-resistance/autophagy-the-first-escape-route.md): What autophagy is, how it works, and why it keeps showing up in ER-positive antiestrogen resistance - [Senescence — the second escape route](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/endocrine-therapy-resistance-and-dormancy/autophagy-and-senescence-in-antiestrogen-resistance/senescence-the-second-escape-route.md): Why treatment-induced senescence can protect surviving cells, and why the review focuses on SASP and senolytics - [Established resistance mechanisms](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/endocrine-therapy-resistance-and-dormancy/autophagy-and-senescence-in-antiestrogen-resistance/established-resistance-mechanisms.md): The main mutations and bypass pathways that may accumulate while ER-positive cells survive in autophagy or senescence - [Glossary and trial notes](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/endocrine-therapy-resistance-and-dormancy/autophagy-and-senescence-in-antiestrogen-resistance/glossary-and-trial-notes.md): Quick definitions for the main terms in this review, plus the current hydroxychloroquine-based trial landscape - [Endocrine Therapy, Stable Disease, and Dormancy in ER-Positive Breast Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/endocrine-therapy-resistance-and-dormancy/endocrine-therapy-stable-disease-and-dormancy-in-er-positive-breast-cancer.md): Why endocrine therapy can help hold ER-positive breast cancer in a long quiet phase, and why late reactivation can still happen - [Slow-Growing ER+ Breast Cancer Cells and How Rac-1 and The IGF Axis Supports Relapse](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/endocrine-therapy-resistance-and-dormancy/slow-growing-er+-breast-cancer-cells-and-how-rac-1-and-the-igf-axis-supports-relapse.md): A new ER+ breast cancer paper shows that some cells survive therapy by going slow, entering a senescent‑like state and wiring in a Rac1–IGF‑axis survival circuit that supports late relapse. - [AI Resistance and the 4-OHE1/E2 Pathway](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/endocrine-therapy-resistance-and-dormancy/ai-resistance-and-the-4-ohe1-e2-pathway.md): How 4-OHE1/E2 handling, methylation, glutathione support, elimination, and melatonin may affect aromatase-inhibitor resistance pressure - [Blood Biopsy Trial — Getting Ahead of Treatment Resistance](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/endocrine-therapy-resistance-and-dormancy/blood-biopsy-trial-getting-ahead-of-treatment-resistance.md): How ctDNA testing and early ESR1 detection may help guide earlier treatment switching in HR-positive, HER2-negative metastatic breast cancer - [Letrozole Side Effects and Possible Considerations](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/letrozole-side-effects-and-possible-considerations.md): Side-effect notes and practical considerations for people using letrozole in HR-positive breast cancer - [COMT Status and Tamoxifen](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/comt-status-and-tamoxifen.md): The crucial COMT-Tamoxifen connection in ER+ breast cancer treatment. - [ER+/PR- Receptor Status](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/er+-pr-receptor-status.md): Research and support notes on what ER-positive, PR-negative receptor status may mean in breast cancer - [Distinguishing Luminal A from Luminal B](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/distinguishing-luminal-a-from-luminal-b.md): Plain-language notes on the difference between Luminal A and Luminal B breast cancer and why the distinction matters - [AR+/ER+ Breast Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/ar+-er+-breast-cancer.md): Deep dive on androgen-receptor-positive, estrogen-receptor-positive breast cancer, including AR-dominant biology, enobosarm logic, resistance questions, and monitoring ideas - [Fulvestrant and the Keto Diet](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/fulvestrant-and-the-keto-diet.md): Research notes on fulvestrant, metabolic context, and the ketogenic-diet question in HR-positive breast cancer - [Genistein Dosing in ER-Positive Breast Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/genistein-dosing-in-er-positive-breast-cancer.md): Research notes on genistein dosing questions in estrogen-receptor-positive breast cancer - [Quercetin Notes on ER+ and Aromatase Modulation](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/quercetin-notes-on-er+-and-aromatase-modulation.md): Notes on quercetin in ER-positive breast cancer, including dose dependency, COMT activity, and aromatase questions - [Gilbert Syndrome, UGT1A1, and Estrogen Detox](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/gilbert-syndrome-ugt1a1-and-estrogen-detox.md): Research and support notes on Gilbert syndrome, UGT1A1, and estrogen-handling questions in breast-cancer context - [Androgen Modulation's Role in Healing Breast Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/androgen-modulations-role-in-healing-breast-cancer.md): Notes on androgen modulation and why it may matter in breast-cancer healing and support discussions - [Support Threads & Docs](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/er-positive-her2-negative/support-threads-and-docs.md): Facebook study-support threads and Google Doc links that apply across breast-cancer subtypes or to broader breast-cancer questions - [Ivermectin & ER+ Breast Cancer: What the 2026 Research Actually Found](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/ivermectin-and-er+-breast-cancer-what-the-2026-research-actually-found.md): Plain-language breakdown of the 2026 ER-positive breast-cancer study showing ivermectin effects on ESR1/ERα, HER2, TGF-β signalling, and tamoxifen synergy - [Triple-Positive](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/triple-positive.md): Overview of triple-positive breast cancer, including what it is and where relevant support threads and overlapping subtype resources currently live - [Triple-Negative](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/triple-negative.md): Overview of triple-negative breast cancer, including biomarkers, standard treatment logic, and common drug names used in this section - [LAR-Subtype Triple-Negative (AR-Positive)](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/triple-negative/lar-subtype-triple-negative-ar-positive.md): Patient guide to luminal androgen receptor TNBC, including biomarkers, trial directions, and supportive research themes - [Treatment Resistance Research](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/triple-negative/treatment-resistance-research.md): Guide to the TNBC resistance section, including natural compounds, repurposed drugs, and emerging resistance-strategy pages - [TNBC Natural Compounds in Treatment Resistance Research](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/triple-negative/treatment-resistance-research/tnbc-natural-compounds-in-treatment-resistance-research.md): Research notes on natural compounds being explored to counter treatment resistance in triple-negative breast cancer, including pterostilbene, blueberries, and piperlongumine - [TNBC Off-Label Drugs in Treatment Resistance Research](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/triple-negative/treatment-resistance-research/tnbc-off-label-drugs-in-treatment-resistance-research.md): Research notes on repurposed off-label drugs being explored to counter treatment resistance in triple-negative breast cancer, including pitavastatin, melatonin, and metformin - [Emerging Resistance Strategies](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/triple-negative/treatment-resistance-research/emerging-resistance-strategies.md): Deeper look at RNA-targeting and multi-target combination strategies being explored for treatment-resistant triple-negative breast cancer - [Post-Chemotherapy Cell Senescence Clean-up](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/post-chemotherapy-cell-senescence-clean-up.md): Study notes on post-chemotherapy senescence, lingering treatment effects, and the idea of senescent-cell clean-up in breast-cancer context - [Dormant Cancer Cells: How to Erase Them](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/dormant-cancer-cells-how-to-erase-them.md): Study summary on breast-cancer dormancy, persistence, and the idea of targeting dormant cells - [Lactoferrin Warning in Breast Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/lactoferrin-warning-in-breast-cancer.md): Research notes on higher-dose lactoferrin and why it raises caution questions in breast-cancer settings - [Collagen When Healing Breast Cancer](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/collagen-when-healing-breast-cancer.md): Research notes on collagen in breast-cancer healing, tissue repair, and the questions this raises in treatment and recovery context - [Radiation Post-First-Line Chemo? 2025 Summary](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/radiation-post-first-line-chemo-2025-summary.md): Research summary on using radiation after first-line chemotherapy and how to think through that choice in breast-cancer context - [Support Threads & Docs](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/support-threads-and-docs.md): Facebook study-support threads and Google Doc links that apply across breast-cancer subtypes or to less subtype-specific breast-cancer questions - [Support Groups](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/support-groups.md): Groups, downloads, and community resources linked to breast-cancer research and support - [Breast Cancer Pathways Project](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/support-groups/breast-cancer-pathways-project.md): Breast cancer pathways worksheets, download guidance, support links, and getting-started pages - [Getting Started](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/support-groups/breast-cancer-pathways-project/getting-started.md): Step-by-step guide to using the Breast Cancer Pathways Project worksheet - [Step 1 — Download the Worksheet](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/support-groups/breast-cancer-pathways-project/step-1-download-the-worksheet.md): How to download, copy, rename, and safely save your worksheet - [Step 2 — Explore Your Worksheet](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/support-groups/breast-cancer-pathways-project/step-2-explore-your-worksheet.md): How to navigate tabs, understand the worksheet structure, and avoid editing the wrong fields - [Step 3 — Standard of Care Choices](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/support-groups/breast-cancer-pathways-project/step-3-standard-of-care-choices.md): How to enter conventional treatment choices so the worksheet can populate the relevant sections - [Step 4 — Typical Dosages](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/support-groups/breast-cancer-pathways-project/step-4-typical-dosages.md): How to interpret the worksheet dosage guidance safely and in context - [Step 5 — Sharing Your Worksheet](https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer/support-groups/breast-cancer-pathways-project/step-5-sharing-your-worksheet.md): How to share your worksheet with practitioners, supporters, or community resources --- # Agent Instructions: Querying This Documentation If you need additional information that is not directly available in this page, you can query the documentation dynamically by asking a question. Perform an HTTP GET request on the current page URL with the `ask` query parameter: ``` GET https://myhealingcommunity.gitbook.io/myhealingcommunity-docs/breast-cancer.md?ask= ``` The question should be specific, self-contained, and written in natural language. The response will contain a direct answer to the question and relevant excerpts and sources from the documentation. Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.